The CANBACK trial, to determine the efficacy of oral cannabidiol, when compared to placebo, as an adjunct for the treatment of acute non-traumatic low back pain.
Phase 2
Not yet recruiting
- Conditions
- Back pain
- Registration Number
- ACTRN12618000487213
- Lead Sponsor
- Dr Bronwyn Bebee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cannabidiol's analgesic effects in acute low back pain?
How does oral cannabidiol compare to NSAIDs in managing acute non-traumatic low back pain?
Are there specific biomarkers that predict response to cannabidiol in back pain patients?
What adverse events are associated with cannabidiol use in emergency department settings?
What are the potential synergies of cannabidiol with other cannabinoids in treating musculoskeletal pain?